UK researchers patent first ibuprofen patch

8 December 2015

Researchers in the UK have patented the world’s first ibuprofen patch which delivers pain relief directly through the skin.

The University of Warwick research team joined forces with Coventry-based bioadhesives company Medherant, to produce a transparent patch that can consistently deliver a prolonged high dose painkiller ibuprofen directly through the skin.

Professor David Haddelton, research chemist at the university, said: “Our technology now means that we can for the first time produce patches that contain effective doses of active ingredients such as ibuprofen for which no patches currently exist. Our success in developing this breakthrough patch design is not limited to ibuprofen. We have also had great results testing the patch with methyl salicylate which is used in liniments, gels and some leading commercial patches.”

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical